1 Questions 2 Answers 0 Followers
Questions related from Igor Age Kos
Would 2 biosimilars, that have separately demonstrated interchangeability with the reference product, through adequate clinical designs (phase III trials with 2 arms, and at least three changes...
24 May 2018 8,787 3 View